Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03364647 · ClinicalTrials.gov registry record · NA
The Effect of Various Strength Training Protocols in ACL Reconstructed Participants
A NA study, sponsored by Brian W. Noehren.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT03364647 is a NA study that has completed, run by Brian W. Noehren. The registered enrollment target is 55 participants.
The verdict
NCT03364647, a NA study, has completed, sponsored by Brian W. Noehren.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
The purpose of the study is to determine how two different blood flow restriction training programs used in conjunction with standard rehabilitation affect leg strength. By doing this study, the investigator hopes to learn if one program improves strength and function more than the other. The investigator also hope to learn how the training affects the properties of muscle in participants who will or have had anterior cruciate ligament (ACL) reconstruction. These results will help define how the training programs are working. There will be no charge to the participant for their physical therapy visits as long as they are part of the study The initial visit and follow up assessment at the end of the training will each take up to 6 hours (2 hours for MRI, 2 muscle biopsy, 2 for muscle strength, movement mechanics and questionaires). The physical therapy visits will range from 60-120 minutes depending on the participant's stage of recovery and the activities to engage in. Training sessions will be held 3 days a week for approximately 4 weeks before surgery and up to 24 weeks after surgery. There will be a total of 4 additional study visits over a 7 month period. The first visit will be used to capture baseline conditions of their knee and thigh muscles (muscle biopsy, MRI, strength). The second visit will occur right before surgery to assess changes during prehabilitation (strength and walking mechanics). The third visit will occur 4-5 months after surgery and will be a complete reevaluation of their thigh muscle and knee function (muscle biopsy, MRI, strength, gait). The last visit will occur 6-7 months after surgery and will involve an assessment of their thigh muscle strength, walking, and jumping form. The muscle biopsy and magnetic resonance imaging portion of the study will occur in the outpatient unit of the Center for Clinical and Translational Science at the UK Medical Center and the MRI center located on the medical center campus. The muscle biopsy will t
Interventions
- OTHER Arm A - blood flow restriction training
- OTHER Arm B - standard of care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2017-08-21 |
| Est. Completion | 2023-10-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03364647
The ClinicalTrials.gov registry entry for NCT03364647 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brian W. Noehren, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Arm A - blood flow restriction training is the first listed.
NCT03364647 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03364647 about?
NCT03364647 is a clinical study titled "The Effect of Various Strength Training Protocols in ACL Reconstructed Participants". The purpose of the study is to determine how two different blood flow restriction training programs used in conjunction with standard rehabilitation affect leg strength. By doing this study, the investigator hopes to learn if one program improves strength and function more than the other. The invest...
What is the current status of trial NCT03364647?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2017-08-21. Estimated completion is 2023-10-06.
What interventions are being tested in trial NCT03364647?
The interventions under investigation include: Arm A - blood flow restriction training (OTHER), Arm B - standard of care (OTHER).
Who is sponsoring clinical trial NCT03364647?
This trial is sponsored by Brian W. Noehren, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.